Glaxo SmithKline Pharmaceuticals Limited

Global Assessment Report on Disaster Risk Reduction 2025

The global cost of disasters is growing: The economic burden of disasters is intensifying. While the direct costs of disasters averaged $70–80 billion a year between 1970 and 2000, between 2001 and 2020 these annual costs grew significantly to $180–200 billion. But the real cost is far higher. Disaster costs …

The long war

A new vaccine will help, but will not defeat malaria. On October 8th researchers announced progress in developing a vaccine against malaria. GlaxoSmithKline (GSK), a British pharmaceutical firm, said it would seek regulatory approval next year for this vaccine, called RTS,S. GSK and its charitable partner, the PATH Malaria Vaccine …

  1. 1

IEP child categories loading...